High Tower Advisors, LLC Immuneering Corp Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Immuneering Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 43,960 shares of IMRX stock, worth $84,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,960Holding current value
$84,403% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding IMRX
# of Institutions
55Shares Held
9.68MCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.88MShares$3.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.06 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny953KShares$1.83 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD859KShares$1.65 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY742KShares$1.42 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $50.7M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...